Literature DB >> 2542329

Characterization of cellular receptors for erythroid differentiation factor on murine erythroleukemia cells.

M Hino1, A Tojo, K Miyazono, Y Miura, S Chiba, Y Eto, H Shibai, F Takaku.   

Abstract

Erythroid differentiation factor (EDF), which is structurally related to transforming growth factor-beta family and induces differentiation of murine erythroleukemia cell clone F5-5, has been labeled with 125I to characterize its interaction with cellular receptors. Binding of 125I-EDF to F5-5 cells is time- and temperature-dependent, specific, saturable, and reversible. Transforming growth factor-beta 1 has no significant effects on growth of F5-5 cells and binding of 125I-EDF to F5-5 cells. Scatchard analysis of the binding data indicated that F5-5 cells have a single class of binding sites (3,200/cell) with an apparent Kd of 3.1 X 10(-10) M. Affinity cross-linking experiments demonstrated three radiolabeled components of 140,000, 76,000, and 67,000 daltons under both reducing and nonreducing conditions. Labeling of these three components has been inhibited by incubation of the cells with excess unlabeled EDF. These results imply molecular weights of 115,000, 51,000, and 42,000 for the EDF receptors on this cell line.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2542329

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Cloning and characterization of a transmembrane serine kinase that acts as an activin type I receptor.

Authors:  K Tsuchida; L S Mathews; W W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

2.  Activin-A binding and biochemical effects in osteoblast-enriched cultures from fetal-rat parietal bone.

Authors:  M Centrella; T L McCarthy; E Canalis
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

3.  The transforming growth factor beta type II receptor can replace the activin type II receptor in inducing mesoderm.

Authors:  A Bhushan; H Y Lin; H F Lodish; C R Kintner
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

4.  Homeoprotein DLX-1 interacts with Smad4 and blocks a signaling pathway from activin A in hematopoietic cells.

Authors:  Shigeru Chiba; Kenichi Takeshita; Yoichi Imai; Keiki Kumano; Mineo Kurokawa; Shigeo Masuda; Kiyoshi Shimizu; Shuji Nakamura; Frank H Ruddle; Hisamaru Hirai
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-11       Impact factor: 11.205

5.  DMSO Enhances TGF-β Activity by Recruiting the Type II TGF-β Receptor From Intracellular Vesicles to the Plasma Membrane.

Authors:  Shuan Shian Huang; Chun-Lin Chen; Franklin W Huang; Wei-Hsien Hou; Jung San Huang
Journal:  J Cell Biochem       Date:  2016-02-18       Impact factor: 4.429

6.  Presence of activin signal transduction in normal ovarian cells and epithelial ovarian carcinoma.

Authors:  I Ito; T Minegishi; J Fukuda; H Shinozaki; N Auersperg; P C Leung
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.